67
Participants
Start Date
May 31, 2001
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
Capecitabine
Irinotecan
Lincoln Medical and Mental Health Center, The Bronx
HemOnCare, P.C., Brooklyn
Fox Chase Cancer Center, Philadelphia
Lombardi Cancer Center at Georgetown University Medical Center, Washington D.C.
George Washington University Medical Center, Washington D.C.
Cancer Center at the University of Virginia, Charlottesville
Charleston Hematology-Oncology, P.A., Charleston
University of Florida Health Science Center - Jacksonville, Jacksonville
Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle
Rockwood Clinic P.S., Spokane
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Eastern Connecticut Hematology and Oncology Associates, Norwich
Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington
St. Louis University Hospital Cancer Center, St Louis
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia
West Virginia University Hospitals, Morgantown
Hoffmann-La Roche
INDUSTRY